Gastrointestinal issues Severe gastrointestinal conditions: Individuals may experience worsening of existing stomach and digestion issues when taking GLP-1 medications
The effective semaglutide dose range in this paradigm (0.010.1 mg/kg for males, 0.03-0.1 mg/kg for females) is consistent with doses reported to reduce alcohol self-administration and intake (0.0003-0.01mg/kg) in rodent and nonhuman primate models (0.003-0.01 mg/kg
In a clinical trial, adults who switched from high-dose injectable obesity drugs to oral GLP-1 pill Foundayo were able to maintain most of their previous weight loss over 1 year, with relatively limited weight regain
Returning a partially used vial to the refrigerator may create condensation and accelerate degradation, compromising future doses
Con cetuximab se han descrito reacciones anafilcticas graves en el 1,2-3,5% de los pacientes, especialmente con la primera infusin del frmaco111, por lo que se recomienda premedicacin con antihistamnicos en todos los casos